EARLY CONCOMITANT IMMUNOMODULATOR TREATMENT PROVIDES ADDITIONAL BENEFIT IN INFLIXIMAB TREATED PEDIATRIC IBD PATIENTS DESPITE PROACTIVE DRUG MONITORING: RETROSPECTIVE ANALYSIS OF A 10-YEAR REAL-LIFE COHORT

Lena Bragagna  1     Hannes Hölz  1     Thu Giang Le Thi  1     Anna Littwin  1     Milena Geist  1     Sibylle Koletzko  1, 2     Tobias Schwerd  2    
1 Dr. von Hauner Children´s Hospital, München, Germany
2 School of Medicine Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing